First in Man Trial - BIOSOLVE-I
NCT01168830
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
de Novo Lesions in Native Coronary Arteries
Interventions
DEVICE:
AMS-3.0
Sponsor
Biotronik AG